Gb002, Inc.
Clinical trials sponsored by Gb002, Inc., explained in plain language.
-
Inhaled drug trial for lung scarring and heart strain halted midway
Disease control TerminatedThis study tests an inhaled medication called seralutinib for people with high blood pressure in the lungs caused by scarring lung disease. The goal is to see if it helps patients walk farther and is safe over the long term. The trial planned to include 480 adults aged 18 to 80, …
Phase: PHASE3 • Sponsor: GB002, Inc. • Aim: Disease control
Last updated May 26, 2026 12:09 UTC
-
Inhaled drug shows promise for Long-Term PAH control
Disease control OngoingThis study looks at the long-term safety and effectiveness of an inhaled medication called seralutinib for people with pulmonary arterial hypertension (PAH), a serious lung condition that makes it hard to breathe. About 316 adults who finished a previous seralutinib study will ta…
Phase: PHASE3 • Sponsor: GB002, Inc. • Aim: Disease control
Last updated May 22, 2026 14:02 UTC